Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis
Open Access
- 2 February 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 2850
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that is often fatal due to the formation of irreversible scar tissue in the distal areas of the lung. Although the pathological and radiological features of IPF lungs are well defined, the lack of insight into the fibrogenic role of fibroblasts that accumulate in distinct anatomical regions of the lungs is a critical knowledge gap. Fibrotic lesions have been shown to originate in the subpleural areas and extend into the lung parenchyma through processes of dysregulated fibroproliferation, migration, fibroblast-to-myofibroblast transformation, and extracellular matrix production. Identifying the molecular targets underlying subpleural thickening at the early and late stages of fibrosis could facilitate the development of new therapies to attenuate fibroblast activation and improve the survival of patients with IPF. Here, we discuss the key cellular and molecular events that contribute to (myo)fibroblast activation and subpleural thickening in IPF. In particular, we highlight the transcriptional programs involved in mesothelial to mesenchymal transformation and fibroblast dysfunction that can be targeted to alter the course of the progressive expansion of fibrotic lesions in the distal areas of IPF lungs.Keywords
Funding Information
- National Heart Lung and Blood Institute (1R01 HL157176, 1R01 HL134801)
This publication has 101 references indexed in Scilit:
- Pulmonary fibrosis: patterns and perpetratorsJournal of Clinical Investigation, 2012
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Recent Developments in Myofibroblast BiologyThe American Journal of Pathology, 2012
- Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transitionProceedings of the National Academy of Sciences of the United States of America, 2011
- Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44Journal of Experimental Medicine, 2011
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherinNature Genetics, 2009
- Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-β1 in vitroAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Mesothelium contributes to vascular smooth muscle and mesenchyme during lung developmentProceedings of the National Academy of Sciences of the United States of America, 2008
- SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentationProceedings of the National Academy of Sciences, 2007